These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25870692)

  • 1. Clinical significance of HPV-DNA testing for precancerous cervical lesions.
    Moarcăs M; Georgescu IC; Brătilă E; Badea M; Cîrstoiu M
    J Med Life; 2014; 7 Spec No. 3(Spec Iss 3):37-9. PubMed ID: 25870692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China.
    Lin CQ; Cui JF; Zhang X; Pan QJ; Chen W; Qiao YL
    Acta Cytol; 2015; 59(5):405-11. PubMed ID: 26565687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital.
    Muangto T; Chanthasenanont A; Lertvutivivat S; Nanthakomon T; Pongrojpaw D; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2016; 17(9):4409-4413. PubMed ID: 27797253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
    J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
    Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
    Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].
    Guo YL; You K; Geng L; Zhang XW; Shen XY; Yao YJ; Fan XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):480-2. PubMed ID: 17068618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
    Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
    Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population.
    Inoue M; Sakaguchi J; Sasagawa T; Tango M
    Int J Gynecol Cancer; 2006; 16(3):1007-13. PubMed ID: 16803477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of high-risk human papillomavirus testing in the screening and management of cervical cancer precursors].
    Jin Y; Pan LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):691-6. PubMed ID: 18051730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV-DNA testing for patients with ASC-US helps identify the women who have a high risk for precancerous cervical lesions.
    Moarcăs M; Georgescu IC; Moarcăs R; Badea M; Cîrstoiu M
    J Med Life; 2014; 7 Spec No. 3(Spec Iss 3):78-80. PubMed ID: 25870700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S; Steinberg W; Schneider W; Hanrath C
    J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silent High Grade Cervical Intraepithelial Neoplasia in Atypical Smears from Liquid Based Cervical Cytology - Three Years Experience in Thammasat University Hospital.
    Lertvutivivat S; Chanthasenanont A; Chanthasenanont A; Muangto T; Nanthakomon T; Pongrojpaw D; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2016; 17(9):4353-4356. PubMed ID: 27797243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
    Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
    Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of histopathological premalignant lesions and infection caused by high-risk genotypes of human papillomavirus in patients with suspicious cytological and colposcopy results: A prospective study.
    Golubović M; Lopičić M; Terzić N; Đurović M; Mugoša B; Mijović G
    Vojnosanit Pregl; 2017 Jan; 74(1):24-30. PubMed ID: 29350503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical squamous cells of undetermined significance-favour reactive compared to atypical squamous cells of undetermined significance-favour dysplasia: association with cervical intraepithelial lesions and human papillomavirus infection.
    Giovannelli L; Capra G; Lama A; Bustinto T; Genco A; Valenti FM; Pinto G; Matranga D; Ammatuna P
    J Clin Virol; 2005 Aug; 33(4):281-6. PubMed ID: 16036177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat cytology and human papillomavirus screening strategies in detecting preinvasive cervical lesions.
    Li K; Yin R
    Medicine (Baltimore); 2015 Feb; 94(5):e435. PubMed ID: 25654377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.